**Auna S.A. and Surgery Partners Financial Performance Overview**
Auna S.A., operating in Mexico, Peru, and Colombia, reported a 6% year-over-year revenue growth for Q4 2025, attributed to increased high-complexity service volumes and improved cash flow management strategies, particularly in Colombia. The oncology medical loss ratio reached a record low of 48.5%, with a major construction project in partnership with EsSalud set to begin in Lima by 2028.
In contrast, Surgery Partners, with 19 licensed surgical hospitals, experienced a disappointing Q4 2025, with a 2.4% revenue growth and challenges including a shift in patient payer mix affecting profitability. The company performed over 170,000 surgical cases for the year but fell short of its capital deployment goals, resulting in a conservative 2026 earnings guidance with a projected EPS decline of 42.6% to 27 cents. Auna’s shares have seen a 7.1% increase year-to-date, while Surgery Partners’ shares have dropped by 5.6%.
